|
Webinar Overview:
In this webinar, preclinical imaging specialist from Bruker, Todd Sasser, will introduce researchers Zbynek Novy and Milos Petrik from the Institute of Molecular and Translational Medicine at Palacky University.
Novy and Petrik will describe the studies they have conducted into the use of radiolabeled siderophores for the nuclear and optical imaging of both infection and cancer.
The researchers will discuss the use of rabiolabeled siderophores in the detection of Aspergillus fumigatus, a fungus that causes the life-threatening infection invasive aspergillosis (IA).
The presenters will also refer to the preclinical imaging instruments they used, the Albira PET/ SPECT/CT and In-Vivo MS FX PRO systems from Bruker BioSpin. The Albira is a trimodal preclinical nuclear imaging system that uses completely unique continuous crystal technology that has been employed in a range of preclinical disease models including cancer, neurodegenerative and infection disease models.
Key topics:
- Introduction to the use of rabiolabeled siderophores in the detection of Aspergillus fumigatus
- The detection of Aspergillus infection
- The potential of Aspergillussiderophore triacetylfusarinine C
- A discussion on the preclinical imaging instruments used
- What the Bruker In-Vivo Multispectral FX PRO system provides
Who Should Attend?
The webinar will be of interest to anyone working in clinical or nuclear medicine departments, particularly those involved in multimodal imaging of infection and cancer.
It will also contain important information for individuals conducting hospital-based research.
Date: Wednesday 6th December 2017
|
Dr. Milos Petrik
Dr. Milos Petrik is a Researcher at Institute of Molecular and Translational Medicine Palacky University Olomouc, Czech Republic
Dr. Zbynek Novy
Dr. Zbynek Novy is a Researcher at Institute of Molecular and Translational Medicine, Palacky University Olomouc, Czech Republic
Todd Sasser
Todd Sasser, a Field Applications Scientist for Bruker Preclinical Imaging, Billerica, MA, US
AZoNetwork UK Ltd.
|
|
|
|
|
No hay comentarios:
Publicar un comentario